1 Bang YJ, "Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer(ToGA) : a phase 3, open-label, randomised controlled trial" 376 : 687-697, 2010
2 Culty M, "The hyaluronate receptor is a member of the CD44(H-CAM)family of cell surface glycoproteins" 111 (111): 2765-2774, 1990
3 Dalerba P, "Phenotypic characterization of human colorectal cancer stem cells" 104 : 10158-10163, 2007
4 Kim YS, "Molecular genetic characterization of alternatively spliced CD44 transcripts in human stomach carcinoma" 12 : 505-513, 1997
5 Yamamichi K, "Increased expression of CD44v6 mRNA significantly correlates with distant metastasis and poor prognosis in gastric cancer" 79 : 256-262, 1998
6 Yamaguchi A, "Expression of a CD44 variant containing exons 8 to 10 is a useful independent factor for the prediction of prognosis in colorectal cancer patients" 14 : 1122-1127, 1996
7 Yamaguchi A, "Expression of CD44v6 in advanced gastric cancer and its relationship to hematogenous metastasis and long-term prognosis" 79 : 230-235, 2002
8 Yasui W, "Expression of CD44 containing variant exon 9(CD44v9)in gastric adenomas and adenocarcinomas : relation to the proliferation and progression" 12 : 1253-1258, 1998
9 Muller W, "Expression and prognostic value of the CD44splicing variants v5 and v6 in gastric cancer" 183 : 222-227, 1997
10 Mulder JW, "Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins" 344 : 1470-1472, 1994
1 Bang YJ, "Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer(ToGA) : a phase 3, open-label, randomised controlled trial" 376 : 687-697, 2010
2 Culty M, "The hyaluronate receptor is a member of the CD44(H-CAM)family of cell surface glycoproteins" 111 (111): 2765-2774, 1990
3 Dalerba P, "Phenotypic characterization of human colorectal cancer stem cells" 104 : 10158-10163, 2007
4 Kim YS, "Molecular genetic characterization of alternatively spliced CD44 transcripts in human stomach carcinoma" 12 : 505-513, 1997
5 Yamamichi K, "Increased expression of CD44v6 mRNA significantly correlates with distant metastasis and poor prognosis in gastric cancer" 79 : 256-262, 1998
6 Yamaguchi A, "Expression of a CD44 variant containing exons 8 to 10 is a useful independent factor for the prediction of prognosis in colorectal cancer patients" 14 : 1122-1127, 1996
7 Yamaguchi A, "Expression of CD44v6 in advanced gastric cancer and its relationship to hematogenous metastasis and long-term prognosis" 79 : 230-235, 2002
8 Yasui W, "Expression of CD44 containing variant exon 9(CD44v9)in gastric adenomas and adenocarcinomas : relation to the proliferation and progression" 12 : 1253-1258, 1998
9 Muller W, "Expression and prognostic value of the CD44splicing variants v5 and v6 in gastric cancer" 183 : 222-227, 1997
10 Mulder JW, "Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins" 344 : 1470-1472, 1994
11 정규원, "Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2011" 대한암학회 46 (46): 109-123, 2014
12 Thomas L, "CD44H regulates tumor cell migration on hyaluronate-coated substrate" 118 : 971-977, 1992
13 Ishimoto T, "CD44+ slow-cycling tumor cell expansion is triggered by cooperative actions of Wnt and prostaglandin E2 in gastric tumorigenesis" 101 : 673-678, 2010
14 Ishimoto T, "CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-)and thereby promotes tumor growth" 19 : 387-400, 2011
15 Hirata K, "CD44 variant 9 expression in primary early gastric cancer as a predictive marker for recurrence" 109 : 379-386, 2013
16 Aruffo A, "CD44 is the principal cell surface receptor for hyaluronate" 61 : 1303-1313, 1990
17 Gunthert U, "A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells" 65 : 13-24, 1991